Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-17 Sale | 2022-08-17 4:40 pm | Turning Point Therapeutics Inc. | TPTX | George Simeon Director | 2,253,660 | $76 | $171,278,160 | 0 (Indirect Direct) | View |
| 2022-08-17 Sale | 2022-08-17 4:32 pm | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 2,000 | $76 | $152,000 | 0 (Direct) | View |
| 2022-08-17 Sale | 2022-08-17 4:31 pm | Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer | 29,778 | $76 | $2,263,128 | 0 (Direct) | View |
| 2022-08-17 Sale | 2022-08-17 4:29 pm | Turning Point Therapeutics Inc. | TPTX | Sun Brian SVP & General Counsel | 45,000 | $76 | $3,420,000 | 0 (Direct) | View |
| 2022-08-17 Sale | 2022-08-17 4:27 pm | Turning Point Therapeutics Inc. | TPTX | Sabus Steve M SVP & Chief Commercial Officer | 36,667 | $76 | $2,786,692 | 0 (Direct) | View |
| 2022-08-17 Sale | 2022-08-17 4:26 pm | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 41,284 | $76 | $3,137,584 | 0 (Direct) | View |
| 2022-08-17 Sale | 2022-08-17 4:23 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 110,959 | $76 | $8,432,884 | 0 (Direct) | View |
| 2022-07-27 Sale | 2022-07-29 4:18 pm | Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer | 1,183 | $74.94 | $88,654 | 28,700 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:10 pm | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 397 | $36.3 | $14,411 | 65,848 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:09 pm | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 221 | $36.3 | $8,022 | 96,961 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:09 pm | Turning Point Therapeutics Inc. | TPTX | North Annette EVP & General Counsel | 669 | $36.3 | $24,285 | 86,579 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:08 pm | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP & Chief Medical Officer | 669 | $36.3 | $24,285 | 109,188 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:07 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 2,971 | $36.3 | $107,847 | 334,970 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-31 Option Award | 2022-06-01 5:02 pm | N/A 2032-05-30 | Turning Point Therapeutics Inc. | TPTX | Sabus Steve M SVP & Chief Commercial Officer | 201,667 | $0 | 201,667 (Direct) | View |
| 2022-04-11 Option Award | 2022-04-12 6:46 pm | N/A 2032-04-10 | Turning Point Therapeutics Inc. | TPTX | Sun Brian SVP & General Counsel | 240,000 | $0 | 240,000 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:11 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO EVP & Chief Financial Officer | 74,883 | $0 | 88,483 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:10 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 62,400 | $0 | 65,848 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:09 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 74,883 | $0 | 96,961 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:09 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | North Annette EVP & General Counsel | 74,883 | $0 | 86,579 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:08 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP & Chief Medical Officer | 102,350 | $0 | 109,188 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:07 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena President & CEO | 287,040 | $0 | 334,970 (Direct) | View |